LakeShore Biopharma Stock (NASDAQ:YS)
Previous Close
$0.93
52W Range
$0.35 - $1.78
50D Avg
$0.87
200D Avg
$0.66
Market Cap
$192.09M
Avg Vol (3M)
$130.56K
Beta
0.54
Div Yield
-
YS Company Profile
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.
YS Performance
Peer Comparison
| Ticker | Company |
|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. |
| BDRX | Biodexa Pharmaceuticals Plc |
| CNSP | CNS Pharmaceuticals, Inc. |
| VIRI | Virios Therapeutics, Inc. |
| REVB | Revelation Biosciences, Inc. |
| QNRX | Quoin Pharmaceuticals, Ltd. |
| VRAX | Virax Biolabs Group Limited |
| EFTR | eFFECTOR Therapeutics, Inc. |
| IMMX | Immix Biopharma, Inc. |
| ALLR | Allarity Therapeutics, Inc. |
| SONN | Sonnet BioTherapeutics Holdings, Inc. |
| ZURA | Zura Bio Limited |
| CDIO | Cardio Diagnostics Holdings, Inc. |